Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification
Formulation Information
TABLET, FILM COATED
**Dosage:** Oral administration. Adults: One tablet three times daily to be taken before or during meals.
ORAL
Medical Information
**Indication:** It is indicated in treatment of polyneuritis, neuralgia and diabetic neuropathy.
**Contraindications:** It is contraindicated in patients known to be hypersensitive to any of the components. Cyanocobalamin should not be used in patients with early Leber’s disease (hereditary optic nerve atrophy). It is also contraindicated in patients who are hypersensitive to cobalt.
A11DB
维生素B1与维生素B6和/或B12的复方
Manufacturer Information
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
SUNWARD PHARMACEUTICAL PRIVATE LIMITED